← All Helius Medical Technologies, INC filings

Helius Medical Technologies, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
HSDT
Helius Medical Technologies, INC
10-K: Solana Company Pivots to Digital Assets, Reports $40.9M Loss
Solana Company, formerly Helius Medical Technologies, Inc., has strategically shifted its focus to a digital asset treasury centered on Solana tokens, reporting a net loss of $40.9 million for 2025 amidst significant market volatility.
NASDAQ
HSDT
Helius Medical Technologies, INC
10-K: Helius Medical Technologies Reports 2024 Results, Navigates Reimbursement Challenges
Helius Medical Technologies announces its 2024 financial results, highlighting progress in commercialization and regulatory efforts while addressing ongoing reimbursement hurdles.
NASDAQ
HSDT
Helius Medical Technologies, INC
10-K: Helius Medical Technologies Reports 2023 Financial Results, Outlines Path to Reimbursement
Helius Medical Technologies' 2023 annual report details ongoing losses, a manufacturing transition, and progress towards reimbursement for its PoNS device.